155 related articles for article (PubMed ID: 31337863)
1. Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer.
Richardsen E; Andersen S; Al-Saad S; Rakaee M; Nordby Y; Pedersen MI; Ness N; Ingebriktsen LM; Fassina A; Taskén KA; Mills IG; Donnem T; Bremnes RM; Busund LT
Sci Rep; 2019 Jul; 9(1):10662. PubMed ID: 31337863
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
3. High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
Nordby Y; Richardsen E; Ness N; Donnem T; Patel HRH; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Nov; 7(1):16308. PubMed ID: 29176717
[TBL] [Abstract][Full Text] [Related]
4. Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells.
Laursen EB; Fredsøe J; Schmidt L; Strand SH; Kristensen H; Rasmussen AKI; Daugaard TF; Mouritzen P; Høyer S; Kristensen G; Stroomberg HV; Brasso K; Røder MA; Borre M; Sørensen KD
Am J Pathol; 2019 Dec; 189(12):2377-2388. PubMed ID: 31539518
[TBL] [Abstract][Full Text] [Related]
5. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells].
Zhang Y; Hao T; Zhang H; Wei P; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):247-252. PubMed ID: 29773107
[TBL] [Abstract][Full Text] [Related]
6. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
[TBL] [Abstract][Full Text] [Related]
7. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract][Full Text] [Related]
8. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
Pudova EA; Krasnov GS; Nyushko KM; Kobelyatskaya AA; Savvateeva MV; Poloznikov AA; Dolotkazin DR; Klimina KM; Guvatova ZG; Simanovsky SA; Gladysh NS; Tokarev AT; Melnikova NV; Dmitriev AA; Alekseev BY; Kaprin AD; Kiseleva MV; Snezhkina AV; Kudryavtseva AV
BMC Med Genomics; 2020 Sep; 13(Suppl 8):129. PubMed ID: 32948204
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.
Wo Q; Zhang D; Hu L; Lyu J; Xiang F; Zheng W; Shou J; Qi X
Biochem Biophys Res Commun; 2019 Dec; 520(3):586-593. PubMed ID: 31623830
[TBL] [Abstract][Full Text] [Related]
10. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Yan HB; Zhang Y; Cen JM; Wang X; Gan BL; Huang JC; Li JY; Song QH; Li SH; Chen G
Med Sci Monit; 2018 Jul; 24():4807-4822. PubMed ID: 29997385
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
Zheng H; Bai L
Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Tanaka N; Fujimoto K; Konishi N
Mol Carcinog; 2016 Sep; 55(9):1378-86. PubMed ID: 26259043
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
[TBL] [Abstract][Full Text] [Related]
17. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
18. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
19. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
Casanova-Salas I; Rubio-Briones J; Calatrava A; Mancarella C; Masiá E; Casanova J; Fernández-Serra A; Rubio L; Ramírez-Backhaus M; Armiñán A; Domínguez-Escrig J; Martínez F; García-Casado Z; Scotlandi K; Vicent MJ; López-Guerrero JA
J Urol; 2014 Jul; 192(1):252-9. PubMed ID: 24518785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
